Skip to content

Microbot Medical MBOT Deferred Income

Deferred Income at other companies

Citi Trends logo
Citi TrendsCTRN
$1.05M+15.5%
Microbot Medical logo
Microbot MedicalMBOT
$93K
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.6M
Inspired Entertainment logo
Inspired EntertainmentINSE
$25.6M+26.1%
Starfighters Space, Inc.
 logo
Starfighters Space, Inc. FJET
$134K
Intrepid Potash logo
Intrepid PotashIPI
$42.67M-5.0%

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncome.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's deferred income?
Microbot Medical (MBOT) reported deferred income of $93K in Q4 2025.
What does deferred income mean?
Represents payments received from customers or partners for goods or services that have not yet been delivered or earned under the terms of a contract. This liability reflects future performance obligations that the company must satisfy to recognize revenue. Tracking this helps investors understand the company's future revenue potential and the timing of cash inflows.